Final results of the HERMINE cohort: a retrospective and prospective' longitudinal French cohort study of 623 metastatic breast cancer women treated by trastuzumab

被引：0
|
作者：
Extra, J.
Antoine, E. C.
Vincent-Salomon, A.
Le Deley, M. C.
Bergougnoux, L.
Remblier, B.
Vasseur, B.
Namer, M.
机构：
[1] Inst Curie, Paris, France
[2] Clin Hartmann, Neuilly sur Seine, France
[3] Inst Gustave Roussy, Villejuif, France
[4] Ctr Antoine Lacassagne, F-06054 Nice, France
来源：
EJC SUPPLEMENTS | 2005年 / 3卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：116 / 116
页数：1
相关论文
共 50 条
  • [1] Internal and external validity of hermine French cohort study on 623 metastatic breast cancer patients treated with trastuzumab
    Bergougnoux, L.
    Remblier, C.
    Campana, F.
    Barbaza, M-O
    Cropet, C.
    Le Deley, M-C
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2008, 17 : S192 - S193
  • [2] Multiple lines of trastuzumab provide a survival benefit for women with metastatic breast cancer: results from the Hermine cohort study
    Antoine, E. C.
    Extra, J. M.
    Vincent-Salomon, A.
    Bergougnoux, L.
    Campana, F.
    Namer, M.
    [J]. EJC SUPPLEMENTS, 2007, 5 (04): : 213 - 213
  • [3] Favourable effect of continued trastuzumab treatment in metastatic breast cancer patients: results from the French Hermine cohort study.
    Extra, J-M
    Antoine, E-C
    Vincent-Salomon, A.
    Bergougnoux, L.
    Campana, F.
    Namer, M.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S102 - S102
  • [4] Trastuzumab trends to improve the poor prognosis of metastatic breast cancer overexpressing HER2: preliminary results of the HERMINE cohort, on behalf HERMINE oncologists
    Namer, Moise
    Antoine, Eric-Charles
    Salomon, Anne Vincent
    Le Deley, Marie-Cecile
    Remblier, Celine
    Vasseur, Berangere
    Extra, Jean-Marc
    [J]. ANNALS OF ONCOLOGY, 2004, 15 : 29 - 29
  • [5] Effect of trastuzumab treatment as first-line on metastatic breast cancer: final results of the French HERMINE cohort after 2-year follow-up (n=221)
    Namer, M
    Antoine, EC
    Le Deley, MC
    Salomon, AV
    Pau, D
    Remblier, C
    Vasseur, B
    Extra, JM
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 : S95 - S96
  • [6] Long term HER2+metastatic breast cancer survivors treated by trastuzumab: Results from the French cohort study LHORA
    Spano, J. -P.
    Beuzeboc, P.
    Coeffic, D.
    Arnould, L.
    Lortholary, A.
    Andre, F.
    Ferrero, J. -M.
    [J]. BREAST, 2015, 24 (04): : 376 - 383
  • [7] Metastatic breast cancer in elderly women: A retrospective cohort study in Morocco
    Maadin, Kaoutar
    Mellas, Nawfel
    Benbrahim, Zineb
    Oualla, Karima
    Amaadour, Lamiae
    Arifi, Samia
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [8] registHER: Results from a prospective, longitudinal cohort study of women with HER2 positive metastatic breast cancer.
    Rugo, HS
    Yardley, D
    Tan-Chiu, E
    Brufsky, A
    Kaufman, P
    Paik, S
    Ulcickas-Yood, M
    Mayer, M
    Tripathy, D
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2004, 88 : S90 - S90
  • [9] registHER: A prospective, longitudinal cohort study of women with HER2 positive metastatic breast cancer.
    Tanchiu, E
    Kaufman, PA
    Paik, S
    Ulcickas-Yood, M
    Mayer, M
    Tripathy, D
    Rugo, H
    Brufsky, A
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 46S - 46S
  • [10] RISK OF LUNG CANCER AMONG SMOKING WOMEN TREATED WITH RADIOTHERAPY FOR PRIMARY BREAST CANCER: FRENCH PROSPECTIVE COHORT STUDY
    Dohollou, N.
    Blachere, H.
    Galland-Girodet, S.
    Labrosse, D.
    Loba, K.
    Messiah, A.
    Mahi, L.
    [J]. VALUE IN HEALTH, 2019, 22 : S484 - S484
12345